Delivery Order SPE2DB24D3013-SPE2DB25FFLNF
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $3,458.54 to AmerisourceBergen Drug Corp for the supply of Aplenzin ER 348 mg tablets (30-count package) on September 17, 2025, with completion targeted for September 18, 2025. This non-competitive delivery order was issued on a firm fixed-price basis and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a child contract action under AmerisourceBergen's broader...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, has been awarded a delivery order valued at $11,629.80 for Aplenzin ER 348 mg tablets (30-count supply) under a firm fixed-price contract with the Defense Logistics Agency's Medical Supply Chain. The award, issued on August 4, 2025, with an ultimate completion date of August 5, 2025, represents a non-set-aside competitive award. This delivery order falls under AmerisourceBergen's larger Indefinite Delivery Contract (IDC)...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 27, 2025, for the supply of Aplenzin ER 348 mg tablets in quantities of 30 units, with a contract ceiling value of $18,556.71. This firm fixed-price delivery order, which is expected to be completed by August 28, 2025, represents a non-set-aside competitively awarded procurement. The award will be fulfilled from AmerisourceBergen's Corporate Office location in Conshohocken, Pennsylvania, where the...
- On April 24, 2025, the Defense Logistics Agency Medical Supply Chain awarded a delivery order valued at $11,526.63 to AmerisourceBergen Drug Corp for 30-count tablets of Aplenzin ER 348 mg. This firm fixed-price, non-set-aside contract represents a single delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.99 billion pharmaceutical supply vehicle running through December 2026. The pharmaceutical product will be delivered to...
- The Defense Logistics Agency awarded a delivery order valued at $8,340.74 to AmerisourceBergen Drug Corp for the supply of Aplenzin ER 174 mg tablets (30-count units) on October 27, 2025, with an ultimate completion date of October 28, 2025. This competitively awarded, firm fixed-price delivery order represents a non-set-aside contract and will be performed at the vendor's Conshohocken, Pennsylvania location. Aplenzin is a brand-name antidepressant medication containing bupropion, an atypical...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $8,531.68 to AmerisourceBergen Drug Corp for the supply of Aplenzin ER 348 mg tablets (30-count) on June 9, 2025, with an ultimate completion date of June 10, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the contractor's Conshohocken, Pennsylvania facility. AmerisourceBergen Drug Corp is a major pharmaceutical distributor serving as a critical...
- The Defense Logistics Agency Troop Support Medical awarded a firm fixed price delivery order valued at $2,940.29 to Amerisourcebergen Drug Corporation for 348 mg Aplenzin ER tablets. Amerisourcebergen Drug Corporation, a division of Amerisourcebergen Corporation, will deliver the pharmaceutical products to a location in Conshohocken, Pennsylvania by July 11, 2023 in accordance with the terms set forth in the contract. As the Defense Logistics Agency is responsible for worldwide logistics support...
- This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $36,537.34 firm fixed-price delivery order is for the supply of APLENZIN ER 522 MG TABLET 30S, a pharmaceutical product. The contract has an ultimate completion date of March 3, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical division,...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $6,815.42, is for the delivery of APLENZIN ER 348 MG TABLET 30S, a pharmaceutical product. This delivery order is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. The IDC serves...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $11,512.09 firm fixed-price contract is for the delivery of the pharmaceutical product APLENZIN ER 348 MG TABLET 30S. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 between AmerisourceBergen and the DLA Troop Support Medical, which...
- SPE2DB24D3013Indefinite Delivery Contract
- SPE2DB24D3013-SPE2DB25FFLNFDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $3,356.25 to AmerisourceBergen Drug Corp for the supply of Aplenzin ER 174 mg tablets (30-count units) on May 8, 2025, with completion scheduled for May 9, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania. The award represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026, which serves as the comprehensive global pharmaceutical support vehicle for military healthcare programs. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, maintains an extensive portfolio of federal medical supply contracts with the Defense Logistics Agency and supports critical medication needs across the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. The Aplenzin (bupropion extended-release) delivery fulfills pharmaceutical supply requirements for military and veteran healthcare operations, consistent with the company's role as a key vendor for federal medical procurement across multiple therapeutic domains. This transaction exemplifies the routine operational execution of AmerisourceBergen's prime vendor status within the DLA's medical supply chain infrastructure.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.4k | 5/8/25 |